These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23220289)

  • 1. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
    Chaturvedi RK; Beal MF
    Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
    Schapira AH; Olanow CW; Greenamyre JT; Bezard E
    Lancet; 2014 Aug; 384(9942):545-55. PubMed ID: 24954676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and mitochondrial dysfunction in the central nervous system.
    Cardinali DP; Pagano ES; Scacchi Bernasconi PA; Reynoso R; Scacchi P
    Horm Behav; 2013 Feb; 63(2):322-30. PubMed ID: 22391273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.
    Naia L; Ribeiro MJ; Rego AC
    Rev Neurosci; 2011 Dec; 23(1):13-28. PubMed ID: 22150069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetic approaches for neuroprotection in Parkinson's disease.
    Beal MF
    Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.
    Chen CM
    Chang Gung Med J; 2011; 34(2):135-52. PubMed ID: 21539755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
    Browne SE
    Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
    Franco-Iborra S; Vila M; Perier C
    Neuroscientist; 2016 Jun; 22(3):266-77. PubMed ID: 25761946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease.
    Beal MF
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S189-94. PubMed ID: 20082988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF; Giorgini F
    Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic role of coenzyme Q(10) in Parkinson's disease.
    Shults CW
    Pharmacol Ther; 2005 Jul; 107(1):120-30. PubMed ID: 15963354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
    Park JS; Davis RL; Sue CM
    Curr Neurol Neurosci Rep; 2018 Apr; 18(5):21. PubMed ID: 29616350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial approaches for neuroprotection.
    Chaturvedi RK; Beal MF
    Ann N Y Acad Sci; 2008 Dec; 1147():395-412. PubMed ID: 19076459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of mitochondria in the pathogenesis of Huntington's disease].
    Karachitos A; Gałgańska H; Kmita H
    Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.